# A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure

> **NCT00742508** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 41 (actual)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** SK&F-105517-D 10 mg capsule
- **DRUG:** Carvedilol-immediate release (IR) 2.5 mg tablet
- **DRUG:** SK&F-105517-D 20 mg capsule
- **DRUG:** SK&F-105517-D 40 mg capsule
- **DRUG:** Carvedilol-IR 10 mg tablet

## Key facts

- **NCT ID:** NCT00742508
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-28
- **Primary completion:** 2009-08-21
- **Final completion:** 2009-08-21
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742508, "A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00742508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*